{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "15",
                "@timestamp": "2022-01-15T07:59:29.000029-05:00",
                "@year": "2022",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2021-06-03T10:55:36.217Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Doctor of Philosophy Program in Medical Sciences"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "120309141"
                            },
                            "@affiliation-instance-id": "2010682650-b1675a9a8d274d73fc703c0ea16e185f",
                            "ce:source-text": "Doctor of Philosophy Program in Medical Sciences, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "120309141"
                        },
                        "author": [{
                            "ce:given-name": "Nungruthai",
                            "preferred-name": {
                                "ce:given-name": "Nungruthai",
                                "ce:initials": "N.",
                                "ce:surname": "Nilsri",
                                "ce:indexed-name": "Nilsri N."
                            },
                            "@author-instance-id": "2010682650-d146b227d47df591925bee59d8428b70",
                            "@seq": "1",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Nilsri",
                            "@auid": "57219990822",
                            "ce:indexed-name": "Nilsri N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022498",
                            "@country": "tha",
                            "city": "Phitsanulok",
                            "organization": [
                                {"$": "Department of Medical Technology"},
                                {"$": "Faculty of Allied Health Sciences"},
                                {"$": "Naresuan University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60022498",
                                "@dptid": "113018079"
                            },
                            "@affiliation-instance-id": "2010682650-afa17233dfc103b50cfc4bbda5cb43c8",
                            "ce:source-text": "Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand",
                            "@dptid": "113018079"
                        },
                        "author": [{
                            "ce:given-name": "Nungruthai",
                            "preferred-name": {
                                "ce:given-name": "Nungruthai",
                                "ce:initials": "N.",
                                "ce:surname": "Nilsri",
                                "ce:indexed-name": "Nilsri N."
                            },
                            "@author-instance-id": "2010682650-d146b227d47df591925bee59d8428b70",
                            "@seq": "1",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Nilsri",
                            "@auid": "57219990822",
                            "ce:indexed-name": "Nilsri N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Interdisciplinary Program of Biomedical Sciences"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "112245966"
                            },
                            "@affiliation-instance-id": "2010682650-329bf037cbc587f992d3b47d876fce80",
                            "ce:source-text": "Interdisciplinary Program of Biomedical Sciences, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "112245966"
                        },
                        "author": [{
                            "ce:given-name": "Panchalee",
                            "preferred-name": {
                                "ce:given-name": "Panchalee",
                                "ce:initials": "P.",
                                "ce:surname": "Jangprasert",
                                "ce:indexed-name": "Jangprasert P."
                            },
                            "@author-instance-id": "2010682650-bcc8da196c2e941d6a90a1270fe869e3",
                            "@seq": "2",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Jangprasert",
                            "@auid": "15119189000",
                            "ce:indexed-name": "Jangprasert P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60023366",
                            "@country": "tha",
                            "city": "Pathum Thani",
                            "organization": [
                                {"$": "Faculty of Medical Technology"},
                                {"$": "Rangsit University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60023366",
                                "@dptid": "104185763"
                            },
                            "@affiliation-instance-id": "2010682650-d457042a35f377b88ee02b31a5037c35",
                            "ce:source-text": "Faculty of Medical Technology, Rangsit University, Pathum Thani, Thailand",
                            "@dptid": "104185763"
                        },
                        "author": [{
                            "ce:given-name": "Jaturawat",
                            "preferred-name": {
                                "ce:given-name": "Jaturawat",
                                "ce:initials": "J.",
                                "ce:surname": "Pawinwongchai",
                                "ce:indexed-name": "Pawinwongchai J."
                            },
                            "@author-instance-id": "2010682650-39f25e251fc45c1d828ed67b4862d636",
                            "@seq": "3",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pawinwongchai",
                            "@auid": "16307636200",
                            "ce:indexed-name": "Pawinwongchai J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Stem Cell and Cell Therapy Research Unit"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "115351583"
                            },
                            "@affiliation-instance-id": "2010682650-186f99afc3d3dec3933f8f58c23ef310",
                            "ce:source-text": "Stem Cell and Cell Therapy Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "115351583"
                        },
                        "author": [{
                            "ce:given-name": "Nipan",
                            "preferred-name": {
                                "ce:given-name": "Nipan",
                                "ce:initials": "N.",
                                "ce:surname": "Israsena",
                                "ce:indexed-name": "Israsena N."
                            },
                            "@author-instance-id": "2010682650-7bba6d8bf457755fbfec53e56a74e37a",
                            "@seq": "4",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Israsena",
                            "@auid": "8119216100",
                            "ce:indexed-name": "Israsena N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Research Unit in Translational Hematology"},
                                {"$": "Division of Hematology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "100291259"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2010682650-3a56edea0df94420e2c8251cfdba098e",
                            "ce:source-text": "Research Unit in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand",
                            "@dptid": "100291259"
                        },
                        "author": [{
                            "ce:given-name": "Ponlapat",
                            "preferred-name": {
                                "ce:given-name": "Ponlapat",
                                "ce:initials": "P.",
                                "ce:surname": "Rojnuckarin",
                                "ce:indexed-name": "Rojnuckarin P."
                            },
                            "@author-instance-id": "2010682650-83511415bb5fcbd74d6b0394aae90ee1",
                            "@seq": "5",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Rojnuckarin",
                            "@auid": "6603335025",
                            "ce:indexed-name": "Rojnuckarin P."
                        }]
                    }
                ],
                "citation-title": "Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model",
                "abstracts": "© 2021, The Author(s).Activating mutations affecting the JAK-STAT signal transduction is the genetic driver of myeloproliferative neoplasms (MPNs) which comprise polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis. The JAK2p.V617F mutation can produce both erythrocytosis in PV and thrombocytosis in ET, while JAK2 exon 12 mutations cause only erythrocytosis. We hypothesized that these two mutations activated different intracellular signals. In this study, the induced pluripotent stem cells (iPSCs) were used to model JAK2-mutated MPNs. Normal iPSCs underwent lentiviral transduction to overexpress JAK2p.V617F or JAK2p.N542_E543del (JAK2exon12) under a doxycycline-inducible system. The modified iPSCs were differentiated into erythroid cells. Compared with JAK2V617F-iPSCs, JAK2exon12-iPSCs yielded more total CD71+GlycophorinA+ erythroid cells, displayed more mature morphology and expressed more adult hemoglobin after doxycycline induction. Capillary Western immunoassay revealed significantly higher phospho-STAT1 but lower phospho-STAT3 and lower Phospho-AKT in JAK2exon12-iPSCs compared with those of JAK2V617F-iPSCs in response to erythropoietin. Furthermore, interferon alpha and arsenic trioxide were tested on these modified iPSCs to explore their potentials for MPN therapy. Both agents preferentially inhibited proliferation and promoted apoptosis of the iPSCs expressing mutant JAK2 compared with those without doxycycline induction. In conclusion, the modified iPSC model can be used to investigate the mechanisms and search for new therapy of MPNs.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Research Unit in Translational Hematology"},
                            {"$": "Division of Hematology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"}
                        ],
                        "ce:source-text": "Research Unit in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Ponlapat",
                        "ce:initials": "P.",
                        "ce:surname": "Rojnuckarin",
                        "ce:indexed-name": "Rojnuckarin P."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "www.nature.com/srep/index.html",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Scientific Reports",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "11",
                        "@issue": "1"
                    }},
                    "@type": "j",
                    "sourcetitle": "Scientific Reports",
                    "publicationdate": {
                        "month": "12",
                        "year": "2021",
                        "date-text": "December 2021",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Sci. Rep.",
                    "@country": "gbr",
                    "issn": {
                        "$": "20452322",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Nature Research"},
                    "article-number": "5255",
                    "@srcid": "21100200805"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": "1000"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MULT"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "nlm",
                        "chemical": [
                            {"chemical-name": "JAK2 protein, human"},
                            {"chemical-name": "Janus Kinase 2"},
                            {"chemical-name": "STAT Transcription Factors"},
                            {"chemical-name": "STAT1 Transcription Factor"},
                            {"chemical-name": "STAT3 Transcription Factor"}
                        ]
                    }}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNSOC"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "13",
                    "@timestamp": "BST 02:47:58",
                    "@year": "2021",
                    "@month": "03"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2010682650",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "931864329",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2021116568",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20211173924",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20210803693",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2021031520",
                            "@idtype": "SNSOC"
                        },
                        {
                            "$": "20210597936777",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85102201123",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85102201123",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "634514596",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "33664283",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "298817299",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1038/s41598-021-83895-6"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "41",
                "reference": [
                    {
                        "ref-fulltext": "Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405. 10.1182/blood-2016-03-643544 (2016). DOI: 10.1182/blood-2016-03-643544",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2016-03-643544",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84974560145",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "127"},
                                "pagerange": {
                                    "@first": "2391",
                                    "@last": "2405"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Arber",
                                    "ce:indexed-name": "Arber D.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405. 10.1182/blood-2016-03-643544 (2016). DOI: 10.1182/blood-2016-03-643544"
                    },
                    {
                        "ref-fulltext": "Vainchenker, W. & Kralovics, R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 129, 667\u2013679. 10.1182/blood-2016-10-695940 (2017). DOI: 10.1182/blood-2016-10-695940",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2016-10-695940",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85015174256",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "129"},
                                "pagerange": {
                                    "@first": "667",
                                    "@last": "679"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Vainchenker",
                                    "ce:indexed-name": "Vainchenker W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Kralovics",
                                    "ce:indexed-name": "Kralovics R."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Vainchenker, W. & Kralovics, R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 129, 667\u2013679. 10.1182/blood-2016-10-695940 (2017). DOI: 10.1182/blood-2016-10-695940"
                    },
                    {
                        "ref-fulltext": "Rumi, E. & Cazzola, M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 129, 680\u2013692. 10.1182/blood-2016-10-695957 (2017). DOI: 10.1182/blood-2016-10-695957",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2016-10-695957",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85015149842",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "129"},
                                "pagerange": {
                                    "@first": "680",
                                    "@last": "692"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Rumi",
                                    "ce:indexed-name": "Rumi E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Cazzola",
                                    "ce:indexed-name": "Cazzola M."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Rumi, E. & Cazzola, M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 129, 680\u2013692. 10.1182/blood-2016-10-695957 (2017). DOI: 10.1182/blood-2016-10-695957"
                    },
                    {
                        "ref-fulltext": "Tefferi, A. & Pardanani, A. Myeloproliferative neoplasms: A contemporary review. JAMA Oncol. 1, 97\u2013105. 10.1001/jamaoncol.2015.89 (2015). DOI: 10.1001/jamaoncol.2015.89",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Myeloproliferative neoplasms: A contemporary review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1001/jamaoncol.2015.89",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84989775088",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "97",
                                    "@last": "105"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Tefferi",
                                    "ce:indexed-name": "Tefferi A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Pardanani",
                                    "ce:indexed-name": "Pardanani A."
                                }
                            ]},
                            "ref-sourcetitle": "JAMA Oncol."
                        },
                        "ce:source-text": "Tefferi, A. & Pardanani, A. Myeloproliferative neoplasms: A contemporary review. JAMA Oncol. 1, 97\u2013105. 10.1001/jamaoncol.2015.89 (2015). DOI: 10.1001/jamaoncol.2015.89"
                    },
                    {
                        "ref-fulltext": "Levine, R. L., Pardanani, A., Tefferi, A. & Gilliland, D. G. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat. Rev. Cancer 7, 673\u2013683. 10.1038/nrc2210 (2007). DOI: 10.1038/nrc2210",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nrc2210",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34548240698",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "673",
                                    "@last": "683"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Levine",
                                    "ce:indexed-name": "Levine R.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Pardanani",
                                    "ce:indexed-name": "Pardanani A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Tefferi",
                                    "ce:indexed-name": "Tefferi A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Gilliland",
                                    "ce:indexed-name": "Gilliland D.G."
                                }
                            ]},
                            "ref-sourcetitle": "Nat. Rev. Cancer"
                        },
                        "ce:source-text": "Levine, R. L., Pardanani, A., Tefferi, A. & Gilliland, D. G. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat. Rev. Cancer 7, 673\u2013683. 10.1038/nrc2210 (2007). DOI: 10.1038/nrc2210"
                    },
                    {
                        "ref-fulltext": "Wattanapanitch, M. Recent updates on induced pluripotent stem cells in hematological disorders. Stem Cells Int. 2019, 5171032. 10.1155/2019/5171032 (2019). DOI: 10.1155/2019/5171032",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Recent updates on induced pluripotent stem cells in hematological disorders"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1155/2019/5171032",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071197959",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2019"},
                                "pagerange": {"@first": "5171032"}
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "ce:surname": "Wattanapanitch",
                                "ce:indexed-name": "Wattanapanitch M."
                            }]},
                            "ref-sourcetitle": "Stem Cells Int."
                        },
                        "ce:source-text": "Wattanapanitch, M. Recent updates on induced pluripotent stem cells in hematological disorders. Stem Cells Int. 2019, 5171032. 10.1155/2019/5171032 (2019). DOI: 10.1155/2019/5171032"
                    },
                    {
                        "ref-fulltext": "Ye, Z., Chou, B. K. & Cheng, L. Promise and challenges of human iPSC-based hematologic disease modeling and treatment. Int. J. Hematol. 95, 601\u2013609. 10.1007/s12185-012-1095-9 (2012). DOI: 10.1007/s12185-012-1095-9",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Promise and challenges of human iPSC-based hematologic disease modeling and treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s12185-012-1095-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84865010864",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "95"},
                                "pagerange": {
                                    "@first": "601",
                                    "@last": "609"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Ye",
                                    "ce:indexed-name": "Ye Z."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Chou",
                                    "ce:indexed-name": "Chou B.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheng",
                                    "ce:indexed-name": "Cheng L."
                                }
                            ]},
                            "ref-sourcetitle": "Int. J. Hematol."
                        },
                        "ce:source-text": "Ye, Z., Chou, B. K. & Cheng, L. Promise and challenges of human iPSC-based hematologic disease modeling and treatment. Int. J. Hematol. 95, 601\u2013609. 10.1007/s12185-012-1095-9 (2012). DOI: 10.1007/s12185-012-1095-9"
                    },
                    {
                        "ref-fulltext": "Focosi, D. et al. Induced pluripotent stem cells in hematology: Current and future applications. Blood Cancer J. 4, e211. 10.1038/bcj.2014.30 (2014). DOI: 10.1038/bcj.2014.30",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Induced pluripotent stem cells in hematology: Current and future applications"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/bcj.2014.30",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e211",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84901982591",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "4"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Focosi",
                                    "ce:indexed-name": "Focosi D."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Cancer J."
                        },
                        "ce:source-text": "Focosi, D. et al. Induced pluripotent stem cells in hematology: Current and future applications. Blood Cancer J. 4, e211. 10.1038/bcj.2014.30 (2014). DOI: 10.1038/bcj.2014.30"
                    },
                    {
                        "ref-fulltext": "Slukvin, I. I. Hematopoietic specification from human pluripotent stem cells: Current advances and challenges toward de novo generation of hematopoietic stem cells. Blood 122, 4035\u20134046. 10.1182/blood-2013-07-474825 (2013). DOI: 10.1182/blood-2013-07-474825",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Hematopoietic specification from human pluripotent stem cells: Current advances and challenges toward de novo generation of hematopoietic stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2013-07-474825",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84893487797",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "122"},
                                "pagerange": {
                                    "@first": "4035",
                                    "@last": "4046"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "I.I.",
                                "@_fa": "true",
                                "ce:surname": "Slukvin",
                                "ce:indexed-name": "Slukvin I.I."
                            }]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Slukvin, I. I. Hematopoietic specification from human pluripotent stem cells: Current advances and challenges toward de novo generation of hematopoietic stem cells. Blood 122, 4035\u20134046. 10.1182/blood-2013-07-474825 (2013). DOI: 10.1182/blood-2013-07-474825"
                    },
                    {
                        "ref-fulltext": "Morotti, A., Rocca, S., Carra, G., Saglio, G. & Brancaccio, M. Modeling myeloproliferative neoplasms: From mutations to mouse models and back again. Blood Rev. 31, 139\u2013150. 10.1016/j.blre.2016.11.004 (2017). DOI: 10.1016/j.blre.2016.11.004",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Modeling myeloproliferative neoplasms: From mutations to mouse models and back again"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.blre.2016.11.004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85008197582",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "139",
                                    "@last": "150"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Morotti",
                                    "ce:indexed-name": "Morotti A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Rocca",
                                    "ce:indexed-name": "Rocca S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Carra",
                                    "ce:indexed-name": "Carra G."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Saglio",
                                    "ce:indexed-name": "Saglio G."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Brancaccio",
                                    "ce:indexed-name": "Brancaccio M."
                                }
                            ]},
                            "ref-sourcetitle": "Blood Rev."
                        },
                        "ce:source-text": "Morotti, A., Rocca, S., Carra, G., Saglio, G. & Brancaccio, M. Modeling myeloproliferative neoplasms: From mutations to mouse models and back again. Blood Rev. 31, 139\u2013150. 10.1016/j.blre.2016.11.004 (2017). DOI: 10.1016/j.blre.2016.11.004"
                    },
                    {
                        "ref-fulltext": "Teofili, L. et al. Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. Blood 110, 354\u2013359. 10.1182/blood-2007-01-069237 (2007). DOI: 10.1182/blood-2007-01-069237",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2007-01-069237",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34347385613",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "110"},
                                "pagerange": {
                                    "@first": "354",
                                    "@last": "359"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Teofili",
                                    "ce:indexed-name": "Teofili L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Teofili, L. et al. Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. Blood 110, 354\u2013359. 10.1182/blood-2007-01-069237 (2007). DOI: 10.1182/blood-2007-01-069237"
                    },
                    {
                        "ref-fulltext": "Grimwade, L. F. et al. Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms. Br. J. Haematol. 147, 495\u2013506. 10.1111/j.1365-2141.2009.07870.x (2009). DOI: 10.1111/j.1365-2141.2009.07870.x",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1365-2141.2009.07870.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "70350446987",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "147"},
                                "pagerange": {
                                    "@first": "495",
                                    "@last": "506"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Grimwade",
                                    "ce:indexed-name": "Grimwade L.F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br. J. Haematol."
                        },
                        "ce:source-text": "Grimwade, L. F. et al. Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms. Br. J. Haematol. 147, 495\u2013506. 10.1111/j.1365-2141.2009.07870.x (2009). DOI: 10.1111/j.1365-2141.2009.07870.x"
                    },
                    {
                        "ref-fulltext": "Saliba, J. et al. Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients. PLoS ONE 8, e74257. 10.1371/journal.pone.0074257 (2013). DOI: 10.1371/journal.pone.0074257",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0074257",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e74257",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84884172929",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "8"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Saliba",
                                    "ce:indexed-name": "Saliba J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS ONE"
                        },
                        "ce:source-text": "Saliba, J. et al. Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients. PLoS ONE 8, e74257. 10.1371/journal.pone.0074257 (2013). DOI: 10.1371/journal.pone.0074257"
                    },
                    {
                        "ref-fulltext": "Scott, L. M. et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N. Engl. J. Med. 356, 459\u2013468. 10.1056/NEJMoa065202 (2007). DOI: 10.1056/NEJMoa065202",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa065202",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33846660947",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "356"},
                                "pagerange": {
                                    "@first": "459",
                                    "@last": "468"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Scott",
                                    "ce:indexed-name": "Scott L.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Scott, L. M. et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N. Engl. J. Med. 356, 459\u2013468. 10.1056/NEJMoa065202 (2007). DOI: 10.1056/NEJMoa065202"
                    },
                    {
                        "ref-fulltext": "Halupa, A. et al. A novel role for STAT1 in regulating murine erythropoiesis: Deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Blood 105, 552\u2013561. 10.1182/blood-2003-09-3237 (2005). DOI: 10.1182/blood-2003-09-3237",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "A novel role for STAT1 in regulating murine erythropoiesis: Deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2003-09-3237",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "11244323820",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "105"},
                                "pagerange": {
                                    "@first": "552",
                                    "@last": "561"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Halupa",
                                    "ce:indexed-name": "Halupa A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Halupa, A. et al. A novel role for STAT1 in regulating murine erythropoiesis: Deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Blood 105, 552\u2013561. 10.1182/blood-2003-09-3237 (2005). DOI: 10.1182/blood-2003-09-3237"
                    },
                    {
                        "ref-fulltext": "Mascarenhas, M. I. et al. Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation. Blood 127, 2298\u20132309. 10.1182/blood-2015-08-664631 (2016). DOI: 10.1182/blood-2015-08-664631",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2015-08-664631",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84993965591",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "127"},
                                "pagerange": {
                                    "@first": "2298",
                                    "@last": "2309"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.I.",
                                    "@_fa": "true",
                                    "ce:surname": "Mascarenhas",
                                    "ce:indexed-name": "Mascarenhas M.I."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Mascarenhas, M. I. et al. Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation. Blood 127, 2298\u20132309. 10.1182/blood-2015-08-664631 (2016). DOI: 10.1182/blood-2015-08-664631"
                    },
                    {
                        "ref-fulltext": "Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: A decade of progress. Nat. Rev. Drug Discov. 16, 115\u2013130. 10.1038/nrd.2016.245 (2017). DOI: 10.1038/nrd.2016.245",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Induced pluripotent stem cell technology: A decade of progress"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nrd.2016.245",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85006285022",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "115",
                                    "@last": "130"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Shi",
                                    "ce:indexed-name": "Shi Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Inoue",
                                    "ce:indexed-name": "Inoue H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu J.C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Yamanaka",
                                    "ce:indexed-name": "Yamanaka S."
                                }
                            ]},
                            "ref-sourcetitle": "Nat. Rev. Drug Discov."
                        },
                        "ce:source-text": "Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: A decade of progress. Nat. Rev. Drug Discov. 16, 115\u2013130. 10.1038/nrd.2016.245 (2017). DOI: 10.1038/nrd.2016.245"
                    },
                    {
                        "ref-fulltext": "Thomas, H., Foster, G. & Platis, D. Mechanisms of action of interferon and nucleoside analogues. J. Hepatol. 39(Suppl 1), S93-98. 10.1016/s0168-8278(03)00207-1 (2003). DOI: 10.1016/s0168-8278(03)00207-1",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Mechanisms of action of interferon and nucleoside analogues"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/s0168-8278(03)00207-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0141860843",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {
                                    "@first": "S93",
                                    "@last": "S98"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Thomas",
                                    "ce:indexed-name": "Thomas H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Foster",
                                    "ce:indexed-name": "Foster G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Platis",
                                    "ce:indexed-name": "Platis D."
                                }
                            ]},
                            "ref-sourcetitle": "J. Hepatol."
                        },
                        "ce:source-text": "Thomas, H., Foster, G. & Platis, D. Mechanisms of action of interferon and nucleoside analogues. J. Hepatol. 39(Suppl 1), S93-98. 10.1016/s0168-8278(03)00207-1 (2003). DOI: 10.1016/s0168-8278(03)00207-1"
                    },
                    {
                        "ref-fulltext": "Hasselbalch, H. C. & Holmström, M. O. Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: Minimal residual disease and cure?. Semin. Immunopathol. 41, 5\u201319. 10.1007/s00281-018-0700-2 (2019). DOI: 10.1007/s00281-018-0700-2",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: Minimal residual disease and cure?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00281-018-0700-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053553138",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "5",
                                    "@last": "19"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Hasselbalch",
                                    "ce:indexed-name": "Hasselbalch H.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.O.",
                                    "@_fa": "true",
                                    "ce:surname": "Holmström",
                                    "ce:indexed-name": "Holmstrom M.O."
                                }
                            ]},
                            "ref-sourcetitle": "Semin. Immunopathol."
                        },
                        "ce:source-text": "Hasselbalch, H. C. & Holmström, M. O. Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: Minimal residual disease and cure?. Semin. Immunopathol. 41, 5\u201319. 10.1007/s00281-018-0700-2 (2019). DOI: 10.1007/s00281-018-0700-2"
                    },
                    {
                        "ref-fulltext": "Lu, M., Xia, L., Li, Y., Wang, X. & Hoffman, R. The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells. Blood 124, 771\u2013779. 10.1182/blood-2013-11-536854%JBlood (2014). DOI: 10.1182/blood-2013-11-536854%JBlood",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2013-11-536854%JBlood",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84905088528",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "124"},
                                "pagerange": {
                                    "@first": "771",
                                    "@last": "779"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Lu",
                                    "ce:indexed-name": "Lu M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Xia",
                                    "ce:indexed-name": "Xia L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li Y."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang X."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Hoffman",
                                    "ce:indexed-name": "Hoffman R."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Lu, M., Xia, L., Li, Y., Wang, X. & Hoffman, R. The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells. Blood 124, 771\u2013779. 10.1182/blood-2013-11-536854%JBlood (2014). DOI: 10.1182/blood-2013-11-536854%JBlood"
                    },
                    {
                        "ref-fulltext": "Lu, M. et al. Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway. Exp. Hematol. 38, 472\u2013480. 10.1016/j.exphem.2010.03.005 (2010). DOI: 10.1016/j.exphem.2010.03.005",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.exphem.2010.03.005",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77952955507",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "472",
                                    "@last": "480"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Lu",
                                    "ce:indexed-name": "Lu M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Exp. Hematol."
                        },
                        "ce:source-text": "Lu, M. et al. Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway. Exp. Hematol. 38, 472\u2013480. 10.1016/j.exphem.2010.03.005 (2010). DOI: 10.1016/j.exphem.2010.03.005"
                    },
                    {
                        "ref-fulltext": "Schubert, C. et al. Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha. J. Hematol. Oncol. 12, 36. 10.1186/s13045-019-0722-9 (2019). DOI: 10.1186/s13045-019-0722-9",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s13045-019-0722-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063804233",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "36"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Schubert",
                                    "ce:indexed-name": "Schubert C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Hematol. Oncol."
                        },
                        "ce:source-text": "Schubert, C. et al. Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha. J. Hematol. Oncol. 12, 36. 10.1186/s13045-019-0722-9 (2019). DOI: 10.1186/s13045-019-0722-9"
                    },
                    {
                        "ref-fulltext": "Miller, W. H. Jr. Molecular targets of arsenic trioxide in malignant cells. Oncologist 7(Suppl 1), 14\u201319. 10.1634/theoncologist.7-suppl_1-14 (2002). DOI: 10.1634/theoncologist.7-suppl_1-14",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Molecular targets of arsenic trioxide in malignant cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1634/theoncologist.7-suppl_1-14",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0036220360",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "14",
                                    "@last": "19"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "W.H.",
                                "@_fa": "true",
                                "ce:surname": "Miller",
                                "ce:suffix": "Jr.",
                                "ce:indexed-name": "Miller W.H."
                            }]},
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Miller, W. H. Jr. Molecular targets of arsenic trioxide in malignant cells. Oncologist 7(Suppl 1), 14\u201319. 10.1634/theoncologist.7-suppl_1-14 (2002). DOI: 10.1634/theoncologist.7-suppl_1-14"
                    },
                    {
                        "ref-fulltext": "Maslah, N. et al. Specific and synergistic targeting of JAK2V617F cells by interferon alpha and arsenic. Blood 132, 52\u201352. 10.1182/blood-2018-99-112518 (2018). DOI: 10.1182/blood-2018-99-112518",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Specific and synergistic targeting of JAK2V617F cells by interferon alpha and arsenic"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2018-99-112518",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85068155871",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "132"},
                                "pagerange": {"@first": "52"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Maslah",
                                    "ce:indexed-name": "Maslah N."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Maslah, N. et al. Specific and synergistic targeting of JAK2V617F cells by interferon alpha and arsenic. Blood 132, 52\u201352. 10.1182/blood-2018-99-112518 (2018). DOI: 10.1182/blood-2018-99-112518"
                    },
                    {
                        "ref-fulltext": "Tomita, A., Kiyoi, H. & Naoe, T. Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia. Int. J. Hematol. 97, 717\u2013725. 10.1007/s12185-013-1354-4 (2013). DOI: 10.1007/s12185-013-1354-4",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s12185-013-1354-4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84879156094",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "97"},
                                "pagerange": {
                                    "@first": "717",
                                    "@last": "725"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Tomita",
                                    "ce:indexed-name": "Tomita A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Kiyoi",
                                    "ce:indexed-name": "Kiyoi H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Naoe",
                                    "ce:indexed-name": "Naoe T."
                                }
                            ]},
                            "ref-sourcetitle": "Int. J. Hematol."
                        },
                        "ce:source-text": "Tomita, A., Kiyoi, H. & Naoe, T. Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia. Int. J. Hematol. 97, 717\u2013725. 10.1007/s12185-013-1354-4 (2013). DOI: 10.1007/s12185-013-1354-4"
                    },
                    {
                        "ref-fulltext": "Khairul, I., Wang, Q. Q., Jiang, Y. H., Wang, C. & Naranmandura, H. Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget 8, 23905\u201323926. 10.18632/oncotarget.14733 (2017). DOI: 10.18632/oncotarget.14733",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Metabolism, toxicity and anticancer activities of arsenic compounds"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.18632/oncotarget.14733",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85017030315",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "23905",
                                    "@last": "23926"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Khairul",
                                    "ce:indexed-name": "Khairul I."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Q.Q.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Q.Q."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Jiang",
                                    "ce:indexed-name": "Jiang Y.H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang C."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Naranmandura",
                                    "ce:indexed-name": "Naranmandura H."
                                }
                            ]},
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Khairul, I., Wang, Q. Q., Jiang, Y. H., Wang, C. & Naranmandura, H. Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget 8, 23905\u201323926. 10.18632/oncotarget.14733 (2017). DOI: 10.18632/oncotarget.14733"
                    },
                    {
                        "ref-fulltext": "Trakarnsanga, K. et al. Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS. PLoS ONE 9, e100874. 10.1371/journal.pone.0100874 (2014). DOI: 10.1371/journal.pone.0100874",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0100874",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e100874",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84904170251",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "9"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Trakarnsanga",
                                    "ce:indexed-name": "Trakarnsanga K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS ONE"
                        },
                        "ce:source-text": "Trakarnsanga, K. et al. Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS. PLoS ONE 9, e100874. 10.1371/journal.pone.0100874 (2014). DOI: 10.1371/journal.pone.0100874"
                    },
                    {
                        "ref-fulltext": "Focosi, D. & Amabile, G. Induced pluripotent stem cell-derived red blood cells and platelet concentrates: From bench to bedside. Cells 10.3390/cells7010002 (2017). DOI: 10.3390/cells7010002",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Induced pluripotent stem cell-derived red blood cells and platelet concentrates: From bench to bedside"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/cells7010002",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049848311",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Focosi",
                                    "ce:indexed-name": "Focosi D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Amabile",
                                    "ce:indexed-name": "Amabile G."
                                }
                            ]},
                            "ref-sourcetitle": "Cells"
                        },
                        "ce:source-text": "Focosi, D. & Amabile, G. Induced pluripotent stem cell-derived red blood cells and platelet concentrates: From bench to bedside. Cells 10.3390/cells7010002 (2017). DOI: 10.3390/cells7010002"
                    },
                    {
                        "ref-fulltext": "Ingrungruanglert, P. et al. Wiskott\u2013Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation. Thromb Haemost. 113, 792\u2013805. 10.1160/TH14-06-0503 (2015). DOI: 10.1160/TH14-06-0503",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Wiskott\u2013Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1160/TH14-06-0503",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84931281589",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "113"},
                                "pagerange": {
                                    "@first": "792",
                                    "@last": "805"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Ingrungruanglert",
                                    "ce:indexed-name": "Ingrungruanglert P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Thromb Haemost."
                        },
                        "ce:source-text": "Ingrungruanglert, P. et al. Wiskott\u2013Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation. Thromb Haemost. 113, 792\u2013805. 10.1160/TH14-06-0503 (2015). DOI: 10.1160/TH14-06-0503"
                    },
                    {
                        "ref-fulltext": "Sim, X., Cardenas-Diaz, F. L., French, D. L. & Gadue, P. A doxycycline-inducible system for genetic correction of iPSC disease models. Methods Mol. Biol. (Clifton, N.J.) 1353, 13\u201323. 10.1007/7651_2014_179 (2016). DOI: 10.1007/7651_2014_179",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "A doxycycline-inducible system for genetic correction of iPSC disease models"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/7651_2014_179",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84946727639",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1353"},
                                "pagerange": {
                                    "@first": "13",
                                    "@last": "23"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Sim",
                                    "ce:indexed-name": "Sim X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Cardenas-Diaz",
                                    "ce:indexed-name": "Cardenas-Diaz F.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.L.",
                                    "@_fa": "true",
                                    "ce:surname": "French",
                                    "ce:indexed-name": "French D.L."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Gadue",
                                    "ce:indexed-name": "Gadue P."
                                }
                            ]},
                            "ref-sourcetitle": "Methods Mol. Biol. (Clifton, N.J.)"
                        },
                        "ce:source-text": "Sim, X., Cardenas-Diaz, F. L., French, D. L. & Gadue, P. A doxycycline-inducible system for genetic correction of iPSC disease models. Methods Mol. Biol. (Clifton, N.J.) 1353, 13\u201323. 10.1007/7651_2014_179 (2016). DOI: 10.1007/7651_2014_179"
                    },
                    {
                        "ref-fulltext": "Brookhouser, N., Zhang, P., Caselli, R., Kim, J. J. & Brafman, D. A. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer\u2019s disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Res. 24, 160\u2013163. 10.1016/j.scr.2017.06.003 (2017). DOI: 10.1016/j.scr.2017.06.003",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.scr.2017.06.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85020504630",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "160",
                                    "@last": "163"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Brookhouser",
                                    "ce:indexed-name": "Brookhouser N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Caselli",
                                    "ce:indexed-name": "Caselli R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim J.J."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "D.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Brafman",
                                    "ce:indexed-name": "Brafman D.A."
                                }
                            ]},
                            "ref-sourcetitle": "Stem Cell Res."
                        },
                        "ce:source-text": "Brookhouser, N., Zhang, P., Caselli, R., Kim, J. J. & Brafman, D. A. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer\u2019s disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Res. 24, 160\u2013163. 10.1016/j.scr.2017.06.003 (2017). DOI: 10.1016/j.scr.2017.06.003"
                    },
                    {
                        "ref-fulltext": "Yang, J. et al. Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes. Acta Pharmacol. Sin. 32, 1239\u20131245. 10.1038/aps.2011.79 (2011). DOI: 10.1038/aps.2011.79",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/aps.2011.79",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80053919482",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "1239",
                                    "@last": "1245"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Acta Pharmacol. Sin."
                        },
                        "ce:source-text": "Yang, J. et al. Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes. Acta Pharmacol. Sin. 32, 1239\u20131245. 10.1038/aps.2011.79 (2011). DOI: 10.1038/aps.2011.79"
                    },
                    {
                        "ref-fulltext": "Lu, S. J. et al. Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regener. Med. 3, 693\u2013704. 10.2217/17460751.3.5.693 (2008). DOI: 10.2217/17460751.3.5.693",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Robust generation of hemangioblastic progenitors from human embryonic stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2217/17460751.3.5.693",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "55949133244",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "693",
                                    "@last": "704"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Lu",
                                    "ce:indexed-name": "Lu S.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Regener. Med."
                        },
                        "ce:source-text": "Lu, S. J. et al. Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regener. Med. 3, 693\u2013704. 10.2217/17460751.3.5.693 (2008). DOI: 10.2217/17460751.3.5.693"
                    },
                    {
                        "ref-fulltext": "Hasegawa, D. et al. Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction. PLoS ONE 12, e0186879. 10.1371/journal.pone.0186879 (2017). DOI: 10.1371/journal.pone.0186879",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0186879",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e0186879",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85032931600",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "12"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Hasegawa",
                                    "ce:indexed-name": "Hasegawa D."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS ONE"
                        },
                        "ce:source-text": "Hasegawa, D. et al. Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction. PLoS ONE 12, e0186879. 10.1371/journal.pone.0186879 (2017). DOI: 10.1371/journal.pone.0186879"
                    },
                    {
                        "ref-fulltext": "Afzal, M. Z. et al. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation. Stem Cell Res. 17, 657\u2013660. 10.1016/j.scr.2016.11.010 (2016). DOI: 10.1016/j.scr.2016.11.010",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.scr.2016.11.010",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR35",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85028043697",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "657",
                                    "@last": "660"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Afzal",
                                    "ce:indexed-name": "Afzal M.Z."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Stem Cell Res."
                        },
                        "ce:source-text": "Afzal, M. Z. et al. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation. Stem Cell Res. 17, 657\u2013660. 10.1016/j.scr.2016.11.010 (2016). DOI: 10.1016/j.scr.2016.11.010"
                    },
                    {
                        "ref-fulltext": "Ochi, K. et al. Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells. Stem Cells Transl. Med. 3, 792\u2013800. 10.5966/sctm.2013-0216 (2014). DOI: 10.5966/sctm.2013-0216",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.5966/sctm.2013-0216",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR36",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84903511243",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "792",
                                    "@last": "800"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Ochi",
                                    "ce:indexed-name": "Ochi K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Stem Cells Transl. Med."
                        },
                        "ce:source-text": "Ochi, K. et al. Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells. Stem Cells Transl. Med. 3, 792\u2013800. 10.5966/sctm.2013-0216 (2014). DOI: 10.5966/sctm.2013-0216"
                    },
                    {
                        "ref-fulltext": "Tubsuwan, A. et al. Molecular analysis of globin gene expression in different thalassaemia disorders: Individual variation of beta(E) pre-mRNA splicing determine disease severity. Br. J. Haematol. 154, 635\u2013643. 10.1111/j.1365-2141.2011.08770.x (2011). DOI: 10.1111/j.1365-2141.2011.08770.x",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Molecular analysis of globin gene expression in different thalassaemia disorders: Individual variation of beta(E) pre-mRNA splicing determine disease severity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1365-2141.2011.08770.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR37",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80051598243",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "154"},
                                "pagerange": {
                                    "@first": "635",
                                    "@last": "643"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Tubsuwan",
                                    "ce:indexed-name": "Tubsuwan A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br. J. Haematol."
                        },
                        "ce:source-text": "Tubsuwan, A. et al. Molecular analysis of globin gene expression in different thalassaemia disorders: Individual variation of beta(E) pre-mRNA splicing determine disease severity. Br. J. Haematol. 154, 635\u2013643. 10.1111/j.1365-2141.2011.08770.x (2011). DOI: 10.1111/j.1365-2141.2011.08770.x"
                    },
                    {
                        "ref-fulltext": "Bai, H. et al. Definitive hematopoietic multipotent progenitor cells are transiently generated from hemogenic endothelial cells in human pluripotent stem cells. J. Cell. Physiol. 231, 1065\u20131076. 10.1002/jcp.25199 (2016). DOI: 10.1002/jcp.25199",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Definitive hematopoietic multipotent progenitor cells are transiently generated from hemogenic endothelial cells in human pluripotent stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/jcp.25199",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR38",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84956614239",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "231"},
                                "pagerange": {
                                    "@first": "1065",
                                    "@last": "1076"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Bai",
                                    "ce:indexed-name": "Bai H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Cell. Physiol."
                        },
                        "ce:source-text": "Bai, H. et al. Definitive hematopoietic multipotent progenitor cells are transiently generated from hemogenic endothelial cells in human pluripotent stem cells. J. Cell. Physiol. 231, 1065\u20131076. 10.1002/jcp.25199 (2016). DOI: 10.1002/jcp.25199"
                    },
                    {
                        "ref-fulltext": "Qiu, C., Olivier, E. N., Velho, M. & Bouhassira, E. E. Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood 111, 2400\u20132408. 10.1182/blood-2007-07-102087 (2008). DOI: 10.1182/blood-2007-07-102087",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2007-07-102087",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR39",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "39349096630",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "111"},
                                "pagerange": {
                                    "@first": "2400",
                                    "@last": "2408"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Qiu",
                                    "ce:indexed-name": "Qiu C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Olivier",
                                    "ce:indexed-name": "Olivier E.N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Velho",
                                    "ce:indexed-name": "Velho M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Bouhassira",
                                    "ce:indexed-name": "Bouhassira E.E."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Qiu, C., Olivier, E. N., Velho, M. & Bouhassira, E. E. Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood 111, 2400\u20132408. 10.1182/blood-2007-07-102087 (2008). DOI: 10.1182/blood-2007-07-102087"
                    },
                    {
                        "ref-fulltext": "Verger, E. et al. Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo. Blood Cancer J. 8, 94. 10.1038/s41408-018-0133-0 (2018). DOI: 10.1038/s41408-018-0133-0",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41408-018-0133-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR40",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054458326",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "94"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Verger",
                                    "ce:indexed-name": "Verger E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Cancer J."
                        },
                        "ce:source-text": "Verger, E. et al. Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo. Blood Cancer J. 8, 94. 10.1038/s41408-018-0133-0 (2018). DOI: 10.1038/s41408-018-0133-0"
                    },
                    {
                        "ref-fulltext": "Lunghi, P., Costanzo, A., Levrero, M. & Bonati, A. Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73\u2013p53AIP1 apoptotic pathway in leukemia cells. Blood 104, 519\u2013525. 10.1182/blood-2003-08-2743 (2004). DOI: 10.1182/blood-2003-08-2743",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73\u2013p53AIP1 apoptotic pathway in leukemia cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood-2003-08-2743",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR41",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "3142590360",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "104"},
                                "pagerange": {
                                    "@first": "519",
                                    "@last": "525"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Lunghi",
                                    "ce:indexed-name": "Lunghi P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Costanzo",
                                    "ce:indexed-name": "Costanzo A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Levrero",
                                    "ce:indexed-name": "Levrero M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bonati",
                                    "ce:indexed-name": "Bonati A."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Lunghi, P., Costanzo, A., Levrero, M. & Bonati, A. Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73\u2013p53AIP1 apoptotic pathway in leukemia cells. Blood 104, 519\u2013525. 10.1182/blood-2003-08-2743 (2004). DOI: 10.1182/blood-2003-08-2743"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85102201123",
        "dc:description": "Activating mutations affecting the JAK-STAT signal transduction is the genetic driver of myeloproliferative neoplasms (MPNs) which comprise polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis. The JAK2p.V617F mutation can produce both erythrocytosis in PV and thrombocytosis in ET, while JAK2 exon 12 mutations cause only erythrocytosis. We hypothesized that these two mutations activated different intracellular signals. In this study, the induced pluripotent stem cells (iPSCs) were used to model JAK2-mutated MPNs. Normal iPSCs underwent lentiviral transduction to overexpress JAK2p.V617F or JAK2p.N542_E543del (JAK2exon12) under a doxycycline-inducible system. The modified iPSCs were differentiated into erythroid cells. Compared with JAK2V617F-iPSCs, JAK2exon12-iPSCs yielded more total CD71+GlycophorinA+ erythroid cells, displayed more mature morphology and expressed more adult hemoglobin after doxycycline induction. Capillary Western immunoassay revealed significantly higher phospho-STAT1 but lower phospho-STAT3 and lower Phospho-AKT in JAK2exon12-iPSCs compared with those of JAK2V617F-iPSCs in response to erythropoietin. Furthermore, interferon alpha and arsenic trioxide were tested on these modified iPSCs to explore their potentials for MPN therapy. Both agents preferentially inhibited proliferation and promoted apoptosis of the iPSCs expressing mutant JAK2 compared with those without doxycycline induction. In conclusion, the modified iPSC model can be used to investigate the mechanisms and search for new therapy of MPNs.",
        "pubmed-id": "33664283",
        "prism:coverDate": "2021-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85102201123",
        "dc:creator": {"author": [{
            "ce:given-name": "Nungruthai",
            "preferred-name": {
                "ce:given-name": "Nungruthai",
                "ce:initials": "N.",
                "ce:surname": "Nilsri",
                "ce:indexed-name": "Nilsri N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60022498",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498"
                }
            ],
            "ce:surname": "Nilsri",
            "@auid": "57219990822",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219990822",
            "ce:indexed-name": "Nilsri N."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85102201123"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102201123&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85102201123&origin=inward"
            }
        ],
        "source-id": "21100200805",
        "citedby-count": "4",
        "prism:volume": "11",
        "subtype": "ar",
        "dc:title": "Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model",
        "openaccess": "1",
        "prism:issn": "20452322",
        "publishercopyright": "© 2021, The Author(s).",
        "article-number": "5255",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Scientific Reports",
        "openaccessFlag": "true",
        "prism:doi": "10.1038/s41598-021-83895-6",
        "dc:identifier": "SCOPUS_ID:85102201123",
        "dc:publisher": "Nature Research"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Erythropoiesis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Exons",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gene Expression Regulation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Induced Pluripotent Stem Cells",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Janus Kinase 2",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Mutation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Myeloproliferative Disorders",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Polycythemia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Polycythemia Vera",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Primary Myelofibrosis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "STAT Transcription Factors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "STAT1 Transcription Factor",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "STAT3 Transcription Factor",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thrombocythemia, Essential",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thrombocytosis",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Multidisciplinary",
        "@code": "1000",
        "@abbrev": "MULT"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Nungruthai",
            "preferred-name": {
                "ce:given-name": "Nungruthai",
                "ce:initials": "N.",
                "ce:surname": "Nilsri",
                "ce:indexed-name": "Nilsri N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60022498",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498"
                }
            ],
            "ce:surname": "Nilsri",
            "@auid": "57219990822",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219990822",
            "ce:indexed-name": "Nilsri N."
        },
        {
            "ce:given-name": "Panchalee",
            "preferred-name": {
                "ce:given-name": "Panchalee",
                "ce:initials": "P.",
                "ce:surname": "Jangprasert",
                "ce:indexed-name": "Jangprasert P."
            },
            "@seq": "2",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Jangprasert",
            "@auid": "15119189000",
            "author-url": "https://api.elsevier.com/content/author/author_id/15119189000",
            "ce:indexed-name": "Jangprasert P."
        },
        {
            "ce:given-name": "Jaturawat",
            "preferred-name": {
                "ce:given-name": "Jaturawat",
                "ce:initials": "J.",
                "ce:surname": "Pawinwongchai",
                "ce:indexed-name": "Pawinwongchai J."
            },
            "@seq": "3",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60023366",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366"
            },
            "ce:surname": "Pawinwongchai",
            "@auid": "16307636200",
            "author-url": "https://api.elsevier.com/content/author/author_id/16307636200",
            "ce:indexed-name": "Pawinwongchai J."
        },
        {
            "ce:given-name": "Nipan",
            "preferred-name": {
                "ce:given-name": "Nipan",
                "ce:initials": "N.",
                "ce:surname": "Israsena",
                "ce:indexed-name": "Israsena N."
            },
            "@seq": "4",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Israsena",
            "@auid": "8119216100",
            "author-url": "https://api.elsevier.com/content/author/author_id/8119216100",
            "ce:indexed-name": "Israsena N."
        },
        {
            "ce:given-name": "Ponlapat",
            "preferred-name": {
                "ce:given-name": "Ponlapat",
                "ce:initials": "P.",
                "ce:surname": "Rojnuckarin",
                "ce:indexed-name": "Rojnuckarin P."
            },
            "@seq": "5",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Rojnuckarin",
            "@auid": "6603335025",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603335025",
            "ce:indexed-name": "Rojnuckarin P."
        }
    ]}
}}